Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
AKTS
#7638
Aktis Oncology, Inc. Common stock
20.1
3
+4.95%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+4.95%
Monthly Change
-2.66%
6 month change
-25.44%
Cambio anual
-25.44%
Cierres anteriores
19.1
8
Open
20.1
3
Bid
Ask
Low
20.1
3
High
20.1
3
Volumen
12
Markets
Acciones
Tecnología
AKTS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
No hay datos
Noticias
BofA Securities startet Coverage für Akoustis Technologies mit Kaufempfehlung
BofA Securities initiates coverage on Akoustis Technologies stock with Buy rating
TD Cowen startet Coverage für Akoustis Technologies mit Kaufempfehlung
Cowen initiates Akoustis Technologies stock with Buy rating
JPMorgan startet Coverage für Aktis Oncology mit "Overweight"-Rating
Akoustis Technologies stock initiated with Overweight rating by JPMorgan
Wednesday Insider Activity: Mitsui’s $55.6M Berkley Buy Leads the Pack
Insider-Kauf bei Aktis Oncology: Direktor Foley investiert 4,19 Millionen US-Dollar
Aktis Oncology director Foley buys $4.19 million in shares
Aktis Oncology: MPM Funds kauft Aktien im Wert von 20 Mio. US-Dollar
Aktis Oncology: Mpm funds buy shares worth $20m
Aktis Oncology (AKTS) sees $20 million purchase by 10% owner